Overall rank by patents
#5,811
Across all tracked assignees
USPTO PatentsView assignee record - 59 granted patents across 13 technology areas, active 2017–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY).
The verdict
ubiome holds 59 US patents across 13 technology areas, rank #5,811 of 50,000 tracked assignees.
Ubiome, Inc. has been granted 59 US utility patents between 2017 and 2019, placing Ubiome, Inc. at rank #5,811 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.8 claims per patent with primary concentration in G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY). As a US Corporation, Ubiome, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, ubiome sits between Whitewater WEST Industries Ltd. (59 patents, rank #5,807) and Arbutus Biopharma Corporation (58 patents, rank #5,815) - the closest US assignees by grant volume. The composite Innovation Score of 39.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 59 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ubiome, Inc.'s 20.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ubiome, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
WHITEWATER WEST INDUSTRIES LTD.
59 patents
Wagner Spray Tech Corporation
59 patents
WiSys Technology Foundation, Inc.
59 patents
rewardStyle, Inc.
59 patents
uBiome, Inc.
59 patents
AAC Optics (Changzhou) Co., Ltd.
58 patents
ADAP.TV, Inc.
58 patents
AMS Research Corporation
58 patents
ARBUTUS BIOPHARMA CORPORATION
58 patents
What this shows Ubiome holds 59 patents at rank #5,811, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,811 in granted patent volume.
Other assignees with the most granted patents in Ubiome's primary technology class.
ubiome's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 6 | 10.2% |
| 2018 | 1 | 1.7% |
| 2019 | 52 | 88.1% |
Top 13 of 13 technology areas
Overall rank by patents
#5,811
Across all tracked assignees
39.4 out of 100
How to use this portfolio
ubiome's 59 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.